Synopsis
Motivation:
Goals:
Approach:
Results:
566-01-009
ISMRM Abstract
Distinct associations of oxygen extraction fraction with clinical biomarkers in Alzheimer’s and non-Alzheimer’s dementias
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Ballard C, Gauthier S, Corbett A, et al. Alzheimer's disease. the Lancet 2011; 377: 1019–1031.
2. Rogan S and Lippa CF. Alzheimer's disease and other dementias: A review. American Journal of Alzheimer's Disease & Other Dementias® 2002; 17: 11–17. DOI: 10.1177/153331750201700106. [doi]
3. Brion J-P. Neurofibrillary tangles and Alzheimer’s disease. European neurology 1998; 40: 130–140.
4. Shoghi-Jadid K, Small GW, Agdeppa ED, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. The American Journal of Geriatric Psychiatry 2002; 10: 24–35.
5. Goedert M, Sisodia SS and Price DL. Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease. Current Opinion in Neurobiology 1991; 1: 441–447. DOI: https://doi.org/10.1016/0959-4388(91)90067-H. [doi]
6. 2023 Alzheimer's disease facts and figures. Alzheimer's & Dementia 2023; 19: 1598–1695. DOI: https://doi.org/10.1002/alz.13016. [doi]
7. Lovestone S. Alzheimer's disease and other dementias (including pseudodementias). Lishman's Organic Psychiatry: a Textbook of Neuropsychiatry 2009: 543–615.
8. Rosenberg GA, Wallin A, Wardlaw JM, et al. Consensus statement for diagnosis of subcortical small vessel disease. J Cereb Blood Flow Metab 2016; 36: 6–25. DOI: 10.1038/jcbfm.2015.172. [doi]
9. Jiang D and Lu H. Cerebral oxygen extraction fraction MRI: Techniques and applications. Magnetic Resonance in Medicine 2022; 88: 575–600. DOI: https://doi.org/10.1002/mrm.29272. [doi]
10. Kudo K, Liu T, Murakami T, et al. Oxygen extraction fraction measurement using quantitative susceptibility mapping: Comparison with positron emission tomography. Journal of Cerebral Blood Flow & Metabolism 2015; 36: 1424–1433. DOI: 10.1177/0271678X15606713. [doi]
11. Biondetti E, Cho J and Lee H. Cerebral oxygen metabolism from MRI susceptibility. NeuroImage 2023; 276: 120189. DOI: https://doi.org/10.1016/j.neuroimage.2023.120189. [doi]
12. Cho J, Kee Y, Spincemaille P, et al. Cerebral metabolic rate of oxygen (CMRO(2) ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med 2018; 80: 1595–1604. 20180307. DOI: 10.1002/mrm.27135. [doi]
13. Misra A and Cho J. An Optimal, Routinely Applicable Multi-Echo Gradient Echo (mGRE) Data Acquisition Scheme for QQ-based Oxygen Extraction Fraction (OEF) Mapping.
14. Cho J, Zhang S, Kee Y, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO(2) ) mapping. Magn Reson Med 2020; 83: 844–857. 20190910. DOI: 10.1002/mrm.27967. [doi]
15. Cho J, Spincemaille P, Nguyen TD, et al. Temporal clustering, tissue composition, and total variation for mapping oxygen extraction fraction using QSM and quantitative BOLD. Magn Reson Med 2021; 86: 2635–2646. 20210610. DOI: 10.1002/mrm.28875. [doi]
16. Cho J, Zhang J, Spincemaille P, et al. QQ-NET - using deep learning to solve quantitative susceptibility mapping and quantitative blood oxygen level dependent magnitude (QSM+qBOLD or QQ) based oxygen extraction fraction (OEF) mapping. Magn Reson Med 2022; 87: 1583–1594. 20211031. DOI: 10.1002/mrm.29057. [doi]
17. Hubertus S, Thomas S, Cho J, et al. Using an artificial neural network for fast mapping of the oxygen extraction fraction with combined QSM and quantitative BOLD. Magn Reson Med 2019; 82: 2199–2211. 20190704. DOI: 10.1002/mrm.27882. [doi]
18. Cho J, Zhang J, Spincemaille P, et al. Multi-Echo Complex Quantitative Susceptibility Mapping and Quantitative Blood Oxygen Level-Dependent Magnitude (mcQSM + qBOLD or mcQQ) for Oxygen Extraction Fraction (OEF) Mapping. Bioengineering 2024; 11: 131.
19. Cho J, Lee J, An H, et al. Cerebral oxygen extraction fraction (OEF): Comparison of challenge-free gradient echo QSM+qBOLD (QQ) with (15)O PET in healthy adults. J Cereb Blood Flow Metab 2021; 41: 1658–1668. 20201127. DOI: 10.1177/0271678x20973951. [doi]
20. Cho J, Ma Y, Spincemaille P, et al. Cerebral oxygen extraction fraction: Comparison of dual-gas challenge calibrated BOLD with CBF and challenge-free gradient echo QSM+qBOLD. Magn Reson Med 2021; 85: 953–961. 20200811. DOI: 10.1002/mrm.28447. [doi]
21. Elanghovan P, Nguyen T, Spincemaille P, et al. Sensitivity assessment of QSM+qBOLD (or QQ) in detecting elevated oxygen extraction fraction (OEF) in physiological change. J Cereb Blood Flow Metab 2024: 271678x241298584. 20241105. DOI: 10.1177/0271678x241298584. [doi]
22. Zhang S, Cho J, Nguyen TD, et al. Initial Experience of Challenge-Free MRI-Based Oxygen Extraction Fraction Mapping of Ischemic Stroke at Various Stages: Comparison With Perfusion and Diffusion Mapping. Frontiers in Neuroscience 2020; 14. Original Research. DOI: 10.3389/fnins.2020.535441. [doi]
23. Wu D, Zhou Y, Cho J, et al. The Spatiotemporal Evolution of MRI-Derived Oxygen Extraction Fraction and Perfusion in Ischemic Stroke. Frontiers in Neuroscience 2021; 15. Original Research. DOI: 10.3389/fnins.2021.716031. [doi]
24. Zhang S, Cho J, Nguyen TD, et al. Initial experience using combined quantitative susceptibility mapping and quantitative bold oxygen level dependent imaging (QSM+ qBOLD) oxygen extraction fraction for evaluation of acute ischemic stroke.
25. Cho J, Zhang S, Kee Y, et al. Data-driven regularized inversion (DRI) for improved QSM+ qBOLD based CMRO2 Mapping: a feasibility study in healthy subjects and ischemic stroke patients.
26. Yang L, Cho J, Chen T, et al. Oxygen extraction fraction (OEF) assesses cerebral oxygen metabolism of deep gray matter in patients with pre-eclampsia. European Radiology 2022; 32: 6058–6069. DOI: 10.1007/s00330-022-08713-7. [doi]
27. Zhang Q, Sui C, Cho J, et al. Assessing Cerebral Oxygen Metabolism Changes in Patients With Preeclampsia Using Voxel-Based Morphometry of Oxygen Extraction Fraction Maps in Magnetic Resonance Imaging. Korean J Radiol 2023; 24: 324–337. 20230307. DOI: 10.3348/kjr.2022.0652. [doi]
28. Zhuang H, Cho J, Chiang GC-Y, et al. Cerebral oxygen extraction fraction declines with ventricular enlargement in patients with normal pressure hydrocephalus. Clinical Imaging 2023; 97: 22–27. DOI: https://doi.org/10.1016/j.clinimag.2023.02.001. [doi]
29. Cho J, Nguyen TD, Huang W, et al. Brain oxygen extraction fraction mapping in patients with multiple sclerosis. Journal of Cerebral Blood Flow & Metabolism 2021; 42: 338–348. DOI: 10.1177/0271678X211048031. [doi]
30. Xie Y, Zhang S, Wu D, et al. The changes of oxygen extraction fraction in different types of lesions in relapsing–remitting multiple sclerosis: A cross-sectional and longitudinal study. Neurological Sciences 2024; 45: 3939–3949. DOI: 10.1007/s10072-024-07463-2. [doi]
31. Cho J, Nguyen TD, Huang W, et al. Regional oxygen extract fraction mapping (rOEF) of multiple sclerosis brains.
32. Yan S, Lu J, Li Y, et al. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson’s disease. European Radiology 2024; 34: 3074–3083. DOI: 10.1007/s00330-023-10283-1. [doi]
33. Shen N, Zhang S, Cho J, et al. Application of Cluster Analysis of Time Evolution for Magnetic Resonance Imaging -Derived Oxygen Extraction Fraction Mapping: A Promising Strategy for the Genetic Profile Prediction and Grading of Glioma. Frontiers in Neuroscience 2021; 15. Original Research. DOI: 10.3389/fnins.2021.736891. [doi]
34. Hubertus S, Thomas S, Cho J, et al. In MRI-based oxygen extraction fraction and cerebral metabolic rate of oxygen mapping in high-grade glioma using a combined quantitative susceptibility mapping and quantitative blood oxygenation level-dependent approach. Proceedings of the International Society for Magnetic Resonance in Medicine, Montréal, QC, Canada 2019: 11–16.
35. van Grinsven EE, de Leeuw J, Siero JCW, et al. Evaluating Physiological MRI Parameters in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery—A Preliminary Analysis and Case Report. Cancers 15. DOI: 10.3390/cancers15174298. [doi]
36. Wang J, Cho J, Zhang C, et al. Assessment of age-related changes of oxygen extraction fraction in of normal adults using QSM and quantitative BOLD.
37. Wu D, Li Y, Zhang S, et al. Trajectories and sex differences of brain structure, oxygenation and perfusion functions in normal aging. Neuroimage 2024; 302: 120903. 20241024. DOI: 10.1016/j.neuroimage.2024.120903. [doi]
38. Chiang GC, Cho J, Dyke J, et al. Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals. Journal of Neuroimaging 2022; 32: 697–709. DOI: https://doi.org/10.1111/jon.12990. [doi]
39. Zhang S, Ma J, Wu S, et al. Evaluation of MRI-based brain oxygen extraction fraction mapping in patients with systemic lupus erythematosus. Lupus Science & Medicine 2025; 12: e001522. DOI: 10.1136/lupus-2025-001522. [doi]
40. Misra A, Wang Y, Chiang GC, et al. Oxygen extraction fraction is differently associated with pathological biomarkers in Alzheimer’s Disease and non-Alzheimer’s dementias.
41. Misra A, Oros-Peusquens A-M, Reetz K, et al. Assessing Abnormal Oxygen Extraction Fraction and Neural Tissue Susceptibility in Parkinson's Disease. Available at SSRN 5184105.
42. Zhang R, Lin M, Cho J, et al. Oxygen extraction fraction in small vessel disease: relationship to disease burden and progression. Brain 2025; 148: 1950–1962. DOI: 10.1093/brain/awae383. [doi]
43. Yan S, Lu J, Duan B, et al. Potential separation of multiple system atrophy and Parkinson’s disease by susceptibility-derived components. NeuroImage 2025; 318: 121241. DOI: https://doi.org/10.1016/j.neuroimage.2025.121241. [doi]
44. Vallejos G, Khalil MH, Keyes S, et al. Utilizing Oxygen Extraction Fraction to differentiate Multiple Sclerosis from Non-Multiple Sclerosis Fluid-Attenuated Inversion Recovery White Matter Lesions. In: MULTIPLE SCLEROSIS JOURNAL 2024, pp.933–934. SAGE PUBLICATIONS LTD 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND.
45. Hosseini SA, Servaes S, Therriault J, et al. Quantitative evaluation of oxygen extraction fraction (OEF) in Alzheimer's disease: A correlation with tau and amyloid pathology and cognitive status. Journal of the Neurological Sciences 2023; 455. DOI: 10.1016/j.jns.2023.121101. [doi]
46. Cho J, Lv H, Guo L, et al. Neuroimaging of Brain Structure-Function Coupling Mechanism in Neuropsychiatric Disorders. Frontiers Media SA, 2023.
47. Prins ND and Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nature Reviews Neurology 2015; 11: 157–165.
48. Blennow K, Dubois B, Fagan AM, et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers Dement 2015; 11: 58–69. 20140503. DOI: 10.1016/j.jalz.2014.02.004. [doi]
49. Cho J, Kee Y, Spincemaille P, et al. Cerebral metabolic rate of oxygen (CMRO2 ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). Magn Reson Med 2018; 80: 1595–1604. 2018/03/09. DOI: 10.1002/mrm.27135. [doi]
50. Cho J, Zhang S, Kee Y, et al. Cluster analysis of time evolution (CAT) for quantitative susceptibility mapping (QSM) and quantitative blood oxygen level-dependent magnitude (qBOLD)-based oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen (CMRO2 ) mapping. Magn Reson Med 2020; 83: 844–857. 2019/09/11. DOI: 10.1002/mrm.27967. [doi]
51. Hubertus S, Thomas S, Cho J, et al. Comparison of gradient echo and gradient echo sampling of spin echo sequence for the quantification of the oxygen extraction fraction from a combined quantitative susceptibility mapping and quantitative BOLD (QSM+ qBOLD) approach. Magnetic resonance in medicine 2019; 82: 1491–1503.
52. Liu Z, Spincemaille P, Yao Y, et al. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med 2018; 79: 2795–2803. 2017/10/13. DOI: 10.1002/mrm.26946. [doi]
53. Wen Y, Spincemaille P, Nguyen T, et al. Multiecho complex total field inversion method (mcTFI) for improved signal modeling in quantitative susceptibility mapping. Magnetic Resonance in Medicine 2021; 86: 2165–2178. DOI: https://doi.org/10.1002/mrm.28814. [doi]
54. Ma Y, Mazerolle EL, Cho J, et al. Quantification of brain oxygen extraction fraction using QSM and a hyperoxic challenge. Magn Reson Med 2020; 84: 3271–3285. 20200630. DOI: 10.1002/mrm.28390. [doi]
55. Zhang J, Cho J, Zhou D, et al. Quantitative susceptibility mapping-based cerebral metabolic rate of oxygen mapping with minimum local variance. Magn Reson Med 2018; 79: 172–179. 20170310. DOI: 10.1002/mrm.26657. [doi]
56. Zhang J, Zhou D, Nguyen TD, et al. Cerebral metabolic rate of oxygen (CMRO2 ) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM). Magn Reson Med 2017; 77: 1762–1773. 2016/04/28. DOI: 10.1002/mrm.26253. [doi]
57. Zhang J, Liu T, Gupta A, et al. Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM). Magn Reson Med 2015; 74: 945–952. 20140926. DOI: 10.1002/mrm.25463. [doi]
58. Ulrich X and Yablonskiy DA. Separation of cellular and BOLD contributions to T2* signal relaxation. Magn Reson Med 2016; 75: 606–615. 2015/03/11. DOI: 10.1002/mrm.25610. [doi]
59. He X, Zhu M and Yablonskiy DA. Validation of oxygen extraction fraction measurement by qBOLD technique. Magn Reson Med 2008; 60: 882–888. DOI: 10.1002/mrm.21719. [doi]
60. Yablonskiy DA, Sukstanskii AL and He X. Blood oxygenation level-dependent (BOLD)-based techniques for the quantification of brain hemodynamic and metabolic properties - theoretical models and experimental approaches. NMR Biomed 2013; 26: 963–986. 20120828. DOI: 10.1002/nbm.2839. [doi]
61. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341–355. 2002/02/08. DOI: 10.1016/s0896-6273(02)00569-x. [doi]
62. Schwarz CG, Gunter JL, Wiste HJ, et al. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity. Neuroimage Clin 2016; 11: 802–812. 20160530. DOI: 10.1016/j.nicl.2016.05.017. [doi]
63. Chiang GC, Insel PS, Tosun D, et al. Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes. Radiology 2011; 259: 844–851. 20110405. DOI: 10.1148/radiol.11101637. [doi]
64. Kim HG, Park S, Rhee HY, et al. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease. Neuroimage Clin 2017; 16: 429–438. 20170824. DOI: 10.1016/j.nicl.2017.08.019. [doi]
65. Benjamini Y and Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995; 57: 289–300.
66. Garnier-Crussard A, Bougacha S, Wirth M, et al. White matter hyperintensity topography in Alzheimer's disease and links to cognition. Alzheimers Dement 2022; 18: 422–433. 20210728. DOI: 10.1002/alz.12410. [doi]
67. Alban SL, Lynch KM, Ringman JM, et al. The association between white matter hyperintensities and amyloid and tau deposition. Neuroimage Clin 2023; 38: 103383. 20230320. DOI: 10.1016/j.nicl.2023.103383. [doi]
68. Brickman AM and Rizvi B. White matter hyperintensities and Alzheimer's disease: An alternative view of an alternative hypothesis. Alzheimers Dement 2023; 19: 4260–4261. 20230712. DOI: 10.1002/alz.13371. [doi]
69. Moscoso A, Rey-Bretal D, Silva-Rodríguez J, et al. White matter hyperintensities are associated with subthreshold amyloid accumulation. NeuroImage 2020; 218: 116944. DOI: https://doi.org/10.1016/j.neuroimage.2020.116944. [doi]
70. Laing KK, Simoes S, Baena-Caldas GP, et al. Cerebrovascular disease promotes tau pathology in Alzheimer’s disease. Brain Communications 2020; 2. DOI: 10.1093/braincomms/fcaa132. [doi]
71. Jiang D, Lin Z, Liu P, et al. Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular Diseases. J Magn Reson Imaging 2020; 52: 1829–1837. 20200621. DOI: 10.1002/jmri.27264. [doi]
72. Li T, Liu T, Zhang J, et al. Neurovascular coupling dysfunction of visual network organization in Parkinson's disease. Neurobiology of Disease 2023; 188: 106323. DOI: https://doi.org/10.1016/j.nbd.2023.106323. [doi]
73. Eizaguirre MB, Vanotti S, Merino Á, et al. The Role of Information Processing Speed in Clinical and Social Support Variables of Patients with Multiple Sclerosis. J Clin Neurol 2018; 14: 472–477. 20180730. DOI: 10.3988/jcn.2018.14.4.472. [doi]
74. Scheff SW, Price DA, Schmitt FA, et al. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2011; 24: 547–557. DOI: 10.3233/jad-2011-101782. [doi]
75. Henry JD, Crawford JR and Phillips LH. Verbal fluency performance in dementia of the Alzheimer’s type: a meta-analysis. Neuropsychologia 2004; 42: 1212–1222.
76. Medeiros MS, Schumacher-Schuh A, Cardoso AM, et al. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers. PLoS One 2016; 11: e0146129. 20160111. DOI: 10.1371/journal.pone.0146129. [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/566-01-009